Kanes Stephen 4
4 · Sage Therapeutics, Inc. · Filed Feb 8, 2019
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-02-08$150.00/sh−22,948$3,442,200→ 941 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The 941 shares reported as beneficially owned were acquired by the reporting person pursuant to the issuer's employee stock purchase plan.